{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:46:04Z","timestamp":1789685164437,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T00:00:00Z","timestamp":1210809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00213-008-1069-z","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T13:21:09Z","timestamp":1210771269000},"page":"37-46","source":"Crossref","is-referenced-by-count":43,"title":["Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice"],"prefix":"10.1007","volume":"199","author":[{"given":"Gunnar","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Sager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen H.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise T.","family":"Brennum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Th\u00f8gersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Hee Bengtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitta","family":"W\u00f6rtwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Fink-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P. D.","family":"Woldbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,15]]},"reference":[{"key":"1069_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(86)90656-4","volume":"120","author":"PH Andersen","year":"1986","unstructured":"Andersen PH, Nielsen EB, Gr\u00f8nvald FC, Br\u00e6strup C (1986) Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo. Eur J Phamacol 120:143\u2013144","journal-title":"Eur J Phamacol"},{"key":"1069_CR2","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/sj.npp.1301015","volume":"31","author":"AL Auclair","year":"2006","unstructured":"Auclair AL, Kleven MS, Besnard J, Depoort\u00e8re R, Newman-Tancredi A (2006) Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1a receptor activation and dopamine D2 receptor blockade. Neuropsychopharmacology 31:1900\u20131909","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.taap.2004.08.013","volume":"204","author":"MJ Bannon","year":"2005","unstructured":"Bannon MJ (2005) The dopamine transporter: role in neurotoxicity and human disease. Toxicol Appl Pharmacol 204:355\u2013360","journal-title":"Toxicol Appl Pharmacol"},{"key":"1069_CR4","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/sj.npp.1300940","volume":"31","author":"L Bardin","year":"2006","unstructured":"Bardin L, Kleven MS, Barret-Gr\u00e9voz C, Depoort\u00e8re R, Newman-Tancredi A (2006) Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1a agonist properties. Neuropsychopharmacology 31:1869\u20131879","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuropharm.2004.07.007","volume":"47","author":"AC Barrett","year":"2004","unstructured":"Barrett AC, Miller JR, Dohrmann JM, Caine SB (2004) Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 47:256\u2013273","journal-title":"Neuropharmacology"},{"key":"1069_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200102000-00001","volume":"12","author":"PM Beardsley","year":"2001","unstructured":"Beardsley PM, Sokoloff P, Balster RL, Schwartz JC (2001) The D3R partial agonist, BP 897, attenuates the discrimitive stimulus effects of cocaine and d-amphetamine and is not self-administered. Behav Pharmacol 12:1\u201311","journal-title":"Behav Pharmacol"},{"key":"1069_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.jcp.0000169419.38899.5b","volume":"25","author":"TP Beresford","year":"2005","unstructured":"Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF (2005) Aripiprazole in schizophrenia with cocaine dependence; a pilot study. J Clin Psychopharmacol 25:363\u2013366","journal-title":"J Clin Psychopharmacol"},{"key":"1069_CR8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008877-199000140-00009","volume":"1","author":"J Bergman","year":"1990","unstructured":"Bergman J, Kamien JB, Spealman RD (1990) Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behav Pharmacol 1:355\u2013363","journal-title":"Behav Pharmacol"},{"key":"1069_CR9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.euroneuro.2004.07.005","volume":"15","author":"EA Blokhina","year":"2005","unstructured":"Blokhina EA, Kashkin VA, Zvartau EE, Danysz W, Bespalov AY (2005) Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice. Eur Neuropsychopharmacol 15:219\u2013225","journal-title":"Eur Neuropsychopharmacol"},{"key":"1069_CR10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v66n0613","volume":"66","author":"ES Brown","year":"2005","unstructured":"Brown ES, Jeffres J, Liggin JD, Garza M, Beard L (2005) Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotics to aripiprazole. J Clin Psychiatry 66:756\u2013760","journal-title":"J Clin Psychiatry"},{"key":"1069_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","volume":"302","author":"KD Burris","year":"2002","unstructured":"Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381\u2013389","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR12","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.105.092155","volume":"315","author":"ES Burstein","year":"2005","unstructured":"Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weiner DM, Brann MR (2005) Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist. J Pharmacol Exp Ther 315:1278\u20131287","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1126\/science.8099761","volume":"260","author":"SB Caine","year":"1993","unstructured":"Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D3 dopamine receptors. Science 260:1814\u20131816","journal-title":"Science"},{"key":"1069_CR14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008877-199506000-00004","volume":"6","author":"SB Caine","year":"1995","unstructured":"Caine SB, Koob GF (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6:333\u2013347","journal-title":"Behav Pharmacol"},{"key":"1069_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3565(24)35108-0","volume":"291","author":"SB Caine","year":"1999","unstructured":"Caine SB, Negus SS, Mello NK, Bergman J (1999) Effects of dopamine D1-like and D2-like agonists in rats that self-administer cocaine. J Pharmacol Exp Ther 291:353\u2013360","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002130050023","volume":"148","author":"SB Caine","year":"2000","unstructured":"Caine SB, Negus SS, Melle NK (2000) Effects of dopamine D1-like and D2-like agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology 148:41\u201351","journal-title":"Psychopharmacology"},{"key":"1069_CR17","first-page":"585","volume":"266","author":"PM Callahan","year":"1993","unstructured":"Callahan PM, Cunningham KA (1993) Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats. J Pharmacol Exp Ther 266:585\u2013592","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0091-3057(83)90471-9","volume":"18","author":"HE Criswell","year":"1983","unstructured":"Criswell HE, Ridings A (1983) Intravenous self-administration of morphine by na\u00efve mice. Pharmacol Biochem Behav 18:467\u2013470","journal-title":"Pharmacol Biochem Behav"},{"key":"1069_CR19","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1126\/science.1137073","volume":"315","author":"JW Dalley","year":"2007","unstructured":"Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW (2007) Nucleus accumbens D2\/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315:1267\u20131270","journal-title":"Science"},{"key":"1069_CR20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","volume":"26","author":"A DeLeon","year":"2004","unstructured":"DeLeon A, Patel NC, Crismon ML (2004) Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clin Ther 26:649\u2013666","journal-title":"Clin Ther"},{"key":"1069_CR21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopsych.2006.04.010","volume":"61","author":"MW Feltenstein","year":"2007","unstructured":"Feltenstein MW, Altar CA, See RE (2007) Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. Biol Psychiatry 61:582\u2013590","journal-title":"Biol Psychiatry"},{"key":"1069_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jnr.10728","volume":"74","author":"A Fink-Jensen","year":"2003","unstructured":"Fink-Jensen A, Fedorova I, W\u00f6rtwein G, Woldbye DPD, Rasmussen T, Thomsen M, Bolwig TG, Knitowski KM, McKinzie DL, Yamada M, Wess J, Basile A (2003) Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res 74:91\u201396","journal-title":"J Neurosci Res"},{"key":"1069_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02249407","volume":"125","author":"DM Grech","year":"1996","unstructured":"Grech DM, Spealman RD, Bergman J (1996) Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology 125:97\u2013104","journal-title":"Psychopharmacology"},{"key":"1069_CR24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/jpet.106.107920","volume":"320","author":"I Gyerty\u00e1n","year":"2007","unstructured":"Gyerty\u00e1n I, Kiss B, G\u00e1l K, Laszlovszky I, Horv\u00e1th A, H\u00e9mesi LI, S\u00e1ghy K, P\u00e1sztor G, Z\u00e1jer M, Kap\u00e1s M, Csongor \u00c9\u00c1, Dom\u00e1ny G, Tihanyu K, Szombathelyi Z (2007) Effects of RGH-237 [N-{4-[4-(3-Aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active selective dopamine D3 receptor partial agonist in animal models of cocaine abuse. J Pharm Exp Ther 320:1268\u20131278","journal-title":"J Pharm Exp Ther"},{"key":"1069_CR25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","volume":"305","author":"S Kapur","year":"2003","unstructured":"Kapur S, Vanderspek SC, Brownlee BA, Nobrega JN (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305:625\u2013631","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-3565(24)39122-0","volume":"294","author":"TV Khroyan","year":"2000","unstructured":"Khroyan TV, Barret-Laramore RL, Rowlett JK, Spealman RD (2000) Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 294:680\u2013687","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR27","first-page":"329","volume":"274","author":"T Kikuchi","year":"1995","unstructured":"Kikuchi T, Tottori K, Uwahodo Y, Hirose T, Miwa T, Oshiro Y, Morita S (1995) 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. J Pharmacol Exp Ther 274:329\u2013336","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuropharm.2005.02.005","volume":"49","author":"MS Kleven","year":"2005","unstructured":"Kleven MS, Barret-Gr\u00e9voz C, Slot LB, Newman-Tancredi A (2005) Novel antipsychotic agents with 5-HT1a agonist properties: Role of 5-HT1a receptor activation in attenuation of catalepsy induction in rats. Neuropharmacology 49:135\u2013143","journal-title":"Neuropharmacology"},{"key":"1069_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0091-3057(92)90363-K","volume":"41","author":"A Kuzmin","year":"1992","unstructured":"Kuzmin A, Zvartau E, Gessa GL, Martellotta MC, Fratta W (1992) Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-na\u00efve mice. Pharmacol Biochem Behav 41:497\u2013500","journal-title":"Pharmacol Biochem Behav"},{"key":"1069_CR30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","volume":"20","author":"CP Lawler","year":"1999","unstructured":"Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, Mailman RB (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20:612\u2013627","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuropharm.2005.04.022","volume":"49","author":"B Foll Le","year":"2005","unstructured":"Le Foll B, Goldberg SR, Sokoloff P (2005) The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neuropharmacology 49:525\u2013541","journal-title":"Neuropharmacology"},{"key":"1069_CR32","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/sj.npp.1300803","volume":"30","author":"JA Lile","year":"2005","unstructured":"Lile JA, Stoops WW, Vansickel AR, Glaser PEA, Hays LR, Rush CR (2005) Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine in humans. Neuropsychopharmacology 30:2103\u20132114","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-003-1677-6","volume":"172","author":"D Marona-Lewicka","year":"2004","unstructured":"Marona-Lewicka D, Nichols DE (2004) Aripiprazole (OPC-14597) fully substitutes for the 5-HT1a receptor agonist LY293284 in the drug discrimination assay in rats. Psychopharmacology 172:415\u2013421","journal-title":"Psychopharmacology"},{"key":"1069_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","volume":"14","author":"NL Mello","year":"1996","unstructured":"Mello NL, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375\u2013424","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<88::AID-SYN11>3.0.CO;2-L","volume":"30","author":"RJ Moore","year":"1998","unstructured":"Moore RJ, Vinsant SL, Nader MA, Porrino LJ, Friedman DP (1998) Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse 30:88\u201396","journal-title":"Synapse"},{"key":"1069_CR36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nn798","volume":"5","author":"D Morgan","year":"2002","unstructured":"Morgan D, Grant KA, Gage HD, Mach RH, Kaplan JR, Prioleau O, Nader SH, Buchheimer N, Ehrenkaufer RL, Nader MA (2002) Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 5:169\u2013174","journal-title":"Nat Neurosci"},{"key":"1069_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tips.2005.12.003","volume":"27","author":"CP M\u00fcller","year":"2006","unstructured":"M\u00fcller CP, Huston JP (2006) Determining the region-specific contributions of the 5-HT receptors to the psychostimulant effects of cocaine. Trends Pharmacol Sci 27:105\u2013112","journal-title":"Trends Pharmacol Sci"},{"key":"1069_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pneurobio.2007.01.001","volume":"81","author":"CP M\u00fcller","year":"2007","unstructured":"M\u00fcller CP, Carey RJ, Huston JP, Silva MADS (2007) Serotonin and psychostimulant addiction: focus on 5-HT1a-receptors. Prog Neurobiol 81:133\u2013178","journal-title":"Prog Neurobiol"},{"key":"1069_CR39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02247388","volume":"125","author":"MA Nader","year":"1996","unstructured":"Nader MA, Mach RH (1996) Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology 125:13\u201322","journal-title":"Psychopharmacology"},{"key":"1069_CR40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0893-133X(01)00427-4","volume":"27","author":"MA Nader","year":"2002","unstructured":"Nader MA, Daunais JB, Moore T, Nader SH, Moore RJ, Smith HR, Friedman DP, Porrino LJ (2002) Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 27:35\u201346","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR41","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nn1737","volume":"9","author":"MA Nader","year":"2006","unstructured":"Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, Ehrenkaufer R, Mach RH (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9:1050\u20131056","journal-title":"Nat Neurosci"},{"key":"1069_CR42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(03)01857-0","volume":"472","author":"S Nakai","year":"2003","unstructured":"Nakai S, Hirose T, Uwahodo Y, Imaoka T, Okazaki H, Miwa T, Nakai M, Yamada S, Dunn B, Burris KD, Molinoff PB, Tottori K, Altar CA, Kikuchi T (2003) Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. Eur J Pharmacol 472:89\u201397","journal-title":"Eur J Pharmacol"},{"key":"1069_CR43","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/sj.npp.1300983","volume":"31","author":"S Natesan","year":"2006","unstructured":"Natesan S, Reckless GE, Nobrega JN, Fletcher PJ, Kapur S (2006) Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models. Neuropsychopharmacology 31:1854\u20131863","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s002130050177","volume":"129","author":"EB Nielsen","year":"1997","unstructured":"Nielsen EB, Hansen JB, Gr\u00f8nvald FC, Swedberg MDB, Scheideler M (1997) NNC 19-1228 and NNC 22-0031, novel neuroleptics with a \u201cmesolimbic-selective\u201d behavioral profile. Psychopharmacology 129:168\u2013178","journal-title":"Psychopharmacology"},{"key":"1069_CR45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-003-1432-z","volume":"167","author":"NE Paterson","year":"2003","unstructured":"Paterson NE, Semenova S, Gasparini F, Markou A (2003) The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167:257\u2013264","journal-title":"Psychopharmacology"},{"key":"1069_CR46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/22560","volume":"400","author":"M Pilla","year":"1999","unstructured":"Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, Schwartz JC, Everitt BJ, Sokoloff P (1999) Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400:371\u2013375","journal-title":"Nature"},{"key":"1069_CR47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-002-1347-0","volume":"166","author":"DM Platt","year":"2003","unstructured":"Platt DM, Rodefer JS, Rowlett JK, Spealman RD (2003) Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys. Psychopharmacology 166:298\u2013305","journal-title":"Psychopharmacology"},{"key":"1069_CR48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-6147(00)01991-X","volume":"23","author":"L Pulvirenti","year":"2002","unstructured":"Pulvirenti L, Koob GF (2002) Being partial to psychostimulant addiction therapy. Trends Pharmacol Sci 23:151\u2013153","journal-title":"Trends Pharmacol Sci"},{"key":"1069_CR49","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0022-3565(24)37716-X","volume":"286","author":"L Pulvirenti","year":"1998","unstructured":"Pulvirenti L, Balducci C, Piercy M, Koob GF (1998) Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. J Pharmacol Exp Ther 286:1231\u20131238","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR50","volume-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2006","unstructured":"R Development Core Team (2006) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria http:\/\/www.R-project.org"},{"key":"1069_CR51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0376-8716(01)00124-7","volume":"64","author":"R Ranaldi","year":"2001","unstructured":"Ranaldi R, Wang Z, Woolverton WL (2001) Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys. Drug Alcohol Depend 64:209\u2013217","journal-title":"Drug Alcohol Depend"},{"key":"1069_CR52","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0091-3057(98)00003-3","volume":"60","author":"T Rasmussen","year":"1998","unstructured":"Rasmussen T, Swedberg MDB (1998) Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-na\u00efve mice. Pharmacol Biochem Behav 60:567\u2013573","journal-title":"Pharmacol Biochem Behav"},{"key":"1069_CR53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-2999(00)00442-8","volume":"402","author":"T Rasmussen","year":"2000","unstructured":"Rasmussen T, Sauerberg P, Nielsen EB, Swedberg MDB, Thomsen C, Sheardown MJ, Jeppesen L, Calligaro DO, DeLapp NW, Whitesitt C, Ward JS, Shannon HE, Bymaster FP, Fink-Jensen A (2000) Muscarinic receptor agonists decrease cocaine self-administration rates in drug-na\u00efve mice. Eur J Pharmacol 402:241\u2013246","journal-title":"Eur J Pharmacol"},{"key":"1069_CR54","first-page":"E847","volume":"7","author":"EL Riddle","year":"2005","unstructured":"Riddle EL, Fleckenstein AE, Hanson GL (2005) Role of monoamine transporters in mediating psychostimulant effects. APPS Journal 7:E847\u2013E851","journal-title":"APPS Journal"},{"key":"1069_CR55","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","volume":"237","author":"MC Ritz","year":"1987","unstructured":"Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219\u20131223","journal-title":"Science"},{"key":"1069_CR56","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00213-006-0520-2","volume":"191","author":"K Schwabe","year":"2007","unstructured":"Schwabe K, Koch M (2007) Effects of Aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats. Psychopharmacology 191:759\u2013765","journal-title":"Psychopharmacology"},{"key":"1069_CR57","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.271.5255.1586","volume":"271","author":"DW Self","year":"1996","unstructured":"Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996) Opposite modulation of cocaine seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271:1586\u20131589","journal-title":"Science"},{"key":"1069_CR58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0028-3908(95)00059-F","volume":"34","author":"J Semba","year":"1995","unstructured":"Semba J, Watanabe A, Kito S, Toru M (1995) Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain. Neuropharmacology 34:785\u2013791","journal-title":"Neuropharmacology"},{"key":"1069_CR59","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","volume":"28","author":"DA Shapiro","year":"2003","unstructured":"Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu L, Sibley DR, Roth BL, Mailman R (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28:1400\u20131411","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(98)00162-8","volume":"54","author":"RS Sinnott","year":"1999","unstructured":"Sinnott RS, Mach RH, Nader MA (1999) Dopamine D2\/D3 receptors modulate cocaine\u2019s reinforcing and discriminative stimulus effects in rhesus monkeys. Drug Alcohol Depend 54:97\u2013110","journal-title":"Drug Alcohol Depend"},{"key":"1069_CR61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76\u201385","journal-title":"Anal Biochem"},{"key":"1069_CR62","volume-title":"SPSS Base version 13.0 User Manual","author":"SPSS Inc.","year":"2004","unstructured":"SPSS Inc. (2004) SPSS Base version 13.0 User Manual. SPSS Inc., Chicago"},{"key":"1069_CR63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-006-0621-y","volume":"190","author":"AD Stark","year":"2007","unstructured":"Stark AD, Jordan S, Allers KA, Bertekap RL, Chen R, Kannan TM, Molski TF, Yocca FD, Sharp T, Kikuchi T, Burris KD (2007) Interaction of the novel antipsychotic aripiprazole with 5-HT1a and 5-HT2a receptors: functional receptor-binding and in vivo electrophysiological studies. Psychopharmacology 190:373\u2013382","journal-title":"Psychopharmacology"},{"key":"1069_CR64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.drugalcdep.2006.02.004","volume":"84","author":"WW Stoops","year":"2006","unstructured":"Stoops WW, Lile JA, Glaser PEA, Rush CR (2006) A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend 84:206\u2013209","journal-title":"Drug Alcohol Depend"},{"key":"1069_CR65","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0022-3565(24)37511-1","volume":"285","author":"JW Tidey","year":"1998","unstructured":"Tidey JW, Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163\u20131174","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.npp.1301071","volume":"32","author":"JD Urban","year":"2007","unstructured":"Urban JD, Vargas GA, von Zastrow M, Mailman RB (2007) Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology 32:67\u201377","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR67","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/syn.890140210","volume":"14","author":"ND Volkow","year":"1993","unstructured":"Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP (1993) Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169\u2013177","journal-title":"Synapse"},{"key":"1069_CR68","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/ajp.156.1.19","volume":"156","author":"ND Volkow","year":"1999","unstructured":"Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, Pappas N (1999) Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 156:1440\u20131443","journal-title":"Am J Psychiatry"},{"key":"1069_CR69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/syn.10137","volume":"46","author":"ND Volkow","year":"2002","unstructured":"Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas N (2002) Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 46:79\u201382","journal-title":"Synapse"},{"key":"1069_CR70","doi-asserted-by":"crossref","unstructured":"Wee S, Mandyam CD, Lekic DM, Koob GF (2007a) a1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access. Eur Neuropsychopharm (in press)","DOI":"10.1016\/j.euroneuro.2007.08.003"},{"key":"1069_CR71","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/sj.npp.1301353","volume":"32","author":"S Wee","year":"2007","unstructured":"Wee S, Wang Z, Woolverton WL, Pulvirenti L, Koob GF (2007b) Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology 32:2238\u20132247","journal-title":"Neuropsychopharmacology"},{"key":"1069_CR72","first-page":"311","volume":"16","author":"R Weissenborn","year":"1996","unstructured":"Weissenborn R, Deroche V, Koob GF, Weiss F (1996) Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus. Psychopharmacology 16:311\u2013322","journal-title":"Psychopharmacology"},{"key":"1069_CR73","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF02244606","volume":"100","author":"RA Wise","year":"1990","unstructured":"Wise RA, Murray A, Bozarth MA (1990) Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology 100:355\u2013360","journal-title":"Psychopharmacology"},{"key":"1069_CR74","first-page":"678","volume":"230","author":"WL Woolverton","year":"1984","unstructured":"Woolverton WL, Goldberg LI, Ginos J (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678\u2013683","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1069-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1069-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:11:12Z","timestamp":1738224672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1069-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,15]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1069-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,15]]}}}